Show
Sort by
-
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment
-
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment
-
The HBP1 tumor suppressor is a druggable ALK downregulated gene controlling MYCN activity
-
The HBP1 tumor suppressor is a druggable ALK downregulated gene controlling MYCN activity
-
Targeted analysis of TP53 pathway SNPs in neuroblastoma patients
-
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients
-
CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients
-
Characterization of ALK driven molecular networks identifies perturbed RET and cholinergic signaling in neuroblastoma
-
High-throughput lncRNA expression profiling identifies candidate cancer lncRNAs
-
Identification and functional characterization of lncRNAs in cancer